Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Transl Psychiatry ; 3: e254, 2013 Apr 30.
Artículo en Inglés | MEDLINE | ID: mdl-23632458

RESUMEN

Claustrophobia, the well-known fear of being trapped in narrow/closed spaces, is often considered a conditioned response to traumatic experience. Surprisingly, we found that mutations affecting a single gene, encoding a stress-regulated neuronal protein, can cause claustrophobia. Gpm6a-deficient mice develop normally and lack obvious behavioral abnormalities. However, when mildly stressed by single-housing, these mice develop a striking claustrophobia-like phenotype, which is not inducible in wild-type controls, even by severe stress. The human GPM6A gene is located on chromosome 4q32-q34, a region linked to panic disorder. Sequence analysis of 115 claustrophobic and non-claustrophobic subjects identified nine variants in the noncoding region of the gene that are more frequent in affected individuals (P=0.028). One variant in the 3'untranslated region was linked to claustrophobia in two small pedigrees. This mutant mRNA is functional but cannot be silenced by neuronal miR124 derived itself from a stress-regulated transcript. We suggest that loosing dynamic regulation of neuronal GPM6A expression poses a genetic risk for claustrophobia.


Asunto(s)
Glicoproteínas de Membrana/genética , Proteínas del Tejido Nervioso/genética , Trastornos Fóbicos/genética , Adulto , Amígdala del Cerebelo/química , Animales , Conducta Animal , Electrorretinografía , Femenino , Ingeniería Genética/métodos , Heterocigoto , Humanos , Masculino , Ratones , Ratones Endogámicos C57BL , Pruebas Psicológicas , Reflejo de Sobresalto/genética , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Estrés Psicológico/genética
2.
Genes Brain Behav ; 9(6): 592-602, 2010 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-20412316

RESUMEN

Schizophrenia is a devastating disease that affects approximately 1% of the population across cultures. Its neurobiological underpinnings are still unknown. Accordingly, animal models of schizophrenia often lack construct validity. As concordance rate in monozygotic twins amounts to only 50%, environmental risk factors (e.g. neurotrauma, drug abuse, psychotrauma) likely act as necessary 'second hit' to trigger/drive the disease process in a genetically predisposed individual. Valid animal models would have to consider this genetic-environmental interaction. Based on this concept, we designed an experimental approach for modeling a schizophrenia-like phenotype in mice. As dysfunction in synaptic transmission plays a key role in schizophrenia, and complexin2 (CPLX2) gene expression is reduced in hippocampus of schizophrenic patients, we developed a mouse model with Cplx2 null mutation as genetic risk factor and a mild parietal neurotrauma, applied during puberty, as environmental 'second hit'. Several months after lesion, Cplx2 null mutants showed reduced pre-pulse inhibition, deficit of spatial learning and loss of inhibition after MK-801 challenge. These abnormalities were largely absent in lesioned wild-type mice and non-lesioned Cplx2 null mutants. Forced alternation in T-maze, object recognition, social interaction and elevated plus maze tests were unaltered in all groups. The previously reported mild motor phenotype of Cplx2 null mutants was accentuated upon lesion. MRI volumetrical analysis showed a decrease of hippocampal volume exclusively in lesioned Cplx2 null mutants. These findings provide suggestive evidence for the 'second hit' hypothesis of schizophrenia and may offer new tools for the development of advanced treatment strategies.


Asunto(s)
Proteínas Adaptadoras del Transporte Vesicular/deficiencia , Proteínas Adaptadoras del Transporte Vesicular/genética , Proteínas del Tejido Nervioso/deficiencia , Proteínas del Tejido Nervioso/genética , Lóbulo Parietal/lesiones , Esquizofrenia/etiología , Esquizofrenia/genética , Animales , Modelos Animales de Enfermedad , Maleato de Dizocilpina/farmacología , Humanos , Masculino , Aprendizaje por Laberinto/fisiología , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Fenotipo , Reconocimiento en Psicología/fisiología , Reflejo de Sobresalto/fisiología , Factores de Riesgo , Conducta Social , Percepción Espacial/fisiología
3.
Genes Brain Behav ; 8(4): 416-25, 2009 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-19243448

RESUMEN

Autism spectrum disorder (ASD) is a frequent neurodevelopmental disorder characterized by variable clinical severity. Core symptoms are qualitatively impaired communication and social behavior, highly restricted interests and repetitive behaviors. Although recent work on genetic mutations in ASD has shed light on the pathophysiology of the disease, classifying it essentially as a synaptopathy, no treatments are available to date. To develop and test novel ASD treatment approaches, validated and informative animal models are required. Of particular interest, in this context are loss-of-function mutations in the postsynaptic cell adhesion protein neuroligin-4 and point mutations in its homologue neuroligin-3 (NL-3) that were found to cause certain forms of monogenic heritable ASD in humans. Here, we show that NL-3-deficient mice display a behavioral phenotype reminiscent of the lead symptoms of ASD: reduced ultrasound vocalization and a lack of social novelty preference. The latter may be related to an olfactory deficiency observed in the NL-3 mutants. Interestingly, such olfactory phenotype is also present in a subgroup of human ASD patients. Tests for learning and memory showed no gross abnormalities in NL-3 mutants. Also, no alterations were found in time spent in social interaction, prepulse inhibition, seizure propensity and sucrose preference. As often seen in adult ASD patients, total brain volume of NL-3 mutant mice was slightly reduced as assessed by magnetic resonance imaging (MRI). Our findings show that the NL-3 knockout mouse represents a useful animal model for understanding pathophysiological events in monogenic heritable ASD and for developing novel treatment strategies in this devastating human disorder.


Asunto(s)
Trastorno Autístico/genética , Trastorno Autístico/psicología , Proteínas de la Membrana/genética , Proteínas del Tejido Nervioso/genética , Trastornos del Olfato/genética , Trastornos del Olfato/psicología , Animales , Ansiedad/genética , Ansiedad/psicología , Trastorno Autístico/patología , Encéfalo/anatomía & histología , Encéfalo/patología , Moléculas de Adhesión Celular Neuronal , Señales (Psicología) , Imagen por Resonancia Magnética , Aprendizaje por Laberinto/fisiología , Proteínas de la Membrana/deficiencia , Memoria/fisiología , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Actividad Motora/efectos de los fármacos , Proteínas del Tejido Nervioso/deficiencia , Mutación Puntual/fisiología , Equilibrio Postural/fisiología , Reflejo de Sobresalto/genética , Reflejo de Sobresalto/fisiología , Convulsiones/inducido químicamente , Convulsiones/psicología , Conducta Social , Transmisión Sináptica/fisiología , Vocalización Animal/fisiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA